Annual Accounts Receivable
$4.11 M
+$1.30 M+46.23%
December 31, 2024
Summary
- As of March 12, 2025, AGIO annual accounts receivable is $4.11 million, with the most recent change of +$1.30 million (+46.23%) on December 31, 2024.
- During the last 3 years, AGIO annual accounts receivable has risen by +$4.11 million (+100.00%).
- AGIO annual accounts receivable is now -73.18% below its all-time high of $15.32 million, reached on December 31, 2019.
Performance
AGIO Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$4.11 M
+$991.00 K+31.78%
December 31, 2024
Summary
- As of March 12, 2025, AGIO quarterly accounts receivable is $4.11 million, with the most recent change of +$991.00 thousand (+31.78%) on December 31, 2024.
- Over the past year, AGIO quarterly accounts receivable has increased by +$1.30 million (+46.23%).
- AGIO quarterly accounts receivable is now -82.38% below its all-time high of $23.32 million, reached on September 30, 2020.
Performance
AGIO Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
AGIO Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +46.2% | +46.2% |
| 3 y3 years | +100.0% | +46.2% |
| 5 y5 years | -73.2% | +46.2% |
AGIO Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | at high | -100.0% |
| 5 y | 5-year | -73.2% | -100.0% | -82.4% | -100.0% |
| alltime | all time | -73.2% | -100.0% | -82.4% | -100.0% |
Agios Pharmaceuticals Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $4.11 M(+46.2%) | $4.11 M(+31.8%) |
| Sep 2024 | - | $3.12 M(-17.1%) |
| Jun 2024 | - | $3.76 M(+8.9%) |
| Mar 2024 | - | $3.45 M(+22.9%) |
| Dec 2023 | $2.81 M(+27.4%) | $2.81 M(+138.9%) |
| Sep 2023 | - | $1.18 M(-47.8%) |
| Jun 2023 | - | $2.25 M(+26.6%) |
| Mar 2023 | - | $1.78 M(-19.4%) |
| Dec 2022 | $2.21 M(>+9900.0%) | $2.21 M(+21.3%) |
| Sep 2022 | - | $1.82 M(+13.8%) |
| Jun 2022 | - | $1.60 M(+195.9%) |
| Mar 2022 | - | $540.00 K(>+9900.0%) |
| Dec 2021 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2020 | - | $23.32 M(+29.3%) |
| Jun 2020 | - | $18.04 M(-8.5%) |
| Mar 2020 | - | $19.72 M(+28.7%) |
| Dec 2019 | $15.32 M | $15.32 M(+23.4%) |
| Sep 2019 | - | $12.41 M(-14.9%) |
| Jun 2019 | - | $14.59 M(+38.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $10.51 M(+0.7%) |
| Dec 2018 | $10.44 M(+184.5%) | $10.44 M(+25.4%) |
| Sep 2018 | - | $8.33 M(-61.0%) |
| Jun 2018 | - | $21.34 M(+332.9%) |
| Mar 2018 | - | $4.93 M(+34.3%) |
| Dec 2017 | $3.67 M(-24.9%) | $3.67 M(-12.7%) |
| Sep 2017 | - | $4.20 M(-13.2%) |
| Jun 2017 | - | $4.84 M(-57.0%) |
| Mar 2017 | - | $11.27 M(+130.6%) |
| Dec 2016 | $4.89 M(-40.6%) | $4.89 M(-40.3%) |
| Sep 2016 | - | $8.18 M(+4.2%) |
| Jun 2016 | - | $7.85 M(+15.2%) |
| Mar 2016 | - | $6.81 M(-17.2%) |
| Dec 2015 | $8.22 M(+26.7%) | $8.22 M(-9.4%) |
| Sep 2015 | - | $9.08 M(-13.3%) |
| Jun 2015 | - | $10.47 M(+49.3%) |
| Mar 2015 | - | $7.02 M(+8.1%) |
| Dec 2014 | $6.49 M(+1263.9%) | $6.49 M(-65.4%) |
| Sep 2014 | - | $18.76 M(+3841.0%) |
| Dec 2013 | $476.00 K | $476.00 K |
FAQ
- What is Agios Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals annual accounts receivable year-on-year change?
- What is Agios Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals quarterly accounts receivable year-on-year change?
What is Agios Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of AGIO is $4.11 M
What is the all time high annual accounts receivable for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high annual accounts receivable is $15.32 M
What is Agios Pharmaceuticals annual accounts receivable year-on-year change?
Over the past year, AGIO annual accounts receivable has changed by +$1.30 M (+46.23%)
What is Agios Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of AGIO is $4.11 M
What is the all time high quarterly accounts receivable for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high quarterly accounts receivable is $23.32 M
What is Agios Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, AGIO quarterly accounts receivable has changed by +$1.30 M (+46.23%)